Literature DB >> 11453112

Prostaglandin E2 secretion from gingival fibroblasts treated with interleukin-1beta: effects of lipid extracts from Porphyromonas gingivalis or calculus.

F C Nichols1, H Levinbook, M Shnaydman, J Goldschmidt.   

Abstract

Complex lipids of Porphyromonas gingivalis have been identified in lipid extracts from calculus-contaminated root surfaces and in diseased gingival tissues. However, little is known about the biological effects of these complex lipids on host cells. The purpose of this study was to evaluate the effects of P. gingivalis or calculus lipids on prostaglandin secretion from gingival fibroblasts. Lipids were extracted from paired subgingival plaque and teeth samples, and calculus-contaminated root surfaces before and after scaling and root planing, in order to determine the relevant levels of lipid extracts for the treatment of gingival fibroblasts in culture. Primary cultures of gingival fibroblasts were exposed to lipid extracts from either P. gingivalis or calculus/teeth for a period of 7 days. Control and lipid-treated cultures were exposed to human recombinant interleukin-1beta for 48 h and prostaglandin secretion from interleukin-1beta-treated fibroblasts was compared with control and lipid-treated fibroblasts without interleukin-1beta treatment. These experiments demonstrated that P. gingivalis lipids or calculus-tooth lipids potentiate interleukin-1beta-mediated prostaglandin secretory responses from gingival fibroblasts. Additionally, P. gingivalis or calculus-tooth lipid extracts were readily taken up by gingival fibroblasts as measured by bacterial fatty acid recovery in lipid extracts of cultured fibroblasts. These results indicate that bacterial lipid penetration into gingival tissues in combination with a chronic inflammatory response may substantially potentiate prostaglandin secretion from gingival fibroblasts, thereby promoting tissue destructive processes associated with adult periodontitis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11453112     DOI: 10.1034/j.1600-0765.2001.360302.x

Source DB:  PubMed          Journal:  J Periodontal Res        ISSN: 0022-3484            Impact factor:   4.419


  8 in total

1.  Porphyromonas gingivalis Sphingolipid Synthesis Limits the Host Inflammatory Response.

Authors:  F G Rocha; Z D Moye; G Ottenberg; P Tang; D J Campopiano; F C Gibson; M E Davey
Journal:  J Dent Res       Date:  2020-02-27       Impact factor: 6.116

2.  Porphyromonas gingivalis lipids inhibit osteoblastic differentiation and function.

Authors:  Yu-Hsiung Wang; Jin Jiang; Qiang Zhu; Amer Z AlAnezi; Robert B Clark; Xi Jiang; David W Rowe; Frank C Nichols
Journal:  Infect Immun       Date:  2010-06-28       Impact factor: 3.441

Review 3.  Are Sphingolipids and Serine Dipeptide Lipids Underestimated Virulence Factors of Porphyromonas gingivalis?

Authors:  Ingar Olsen; Frank C Nichols
Journal:  Infect Immun       Date:  2018-06-21       Impact factor: 3.441

Review 4.  Influence of obesity on the outcome of non-surgical periodontal therapy - a systematic review.

Authors:  Fabienne A Gerber; Philipp Sahrmann; Oliver A Schmidlin; Christian Heumann; Jürg Hans Beer; Patrick R Schmidlin
Journal:  BMC Oral Health       Date:  2016-09-02       Impact factor: 2.757

5.  Sphingolipid-Containing Outer Membrane Vesicles Serve as a Delivery Vehicle To Limit Macrophage Immune Response to Porphyromonas gingivalis.

Authors:  Fernanda G Rocha; Gregory Ottenberg; Zavier G Eure; Mary E Davey; Frank C Gibson
Journal:  Infect Immun       Date:  2021-03-17       Impact factor: 3.441

6.  A review of novel bacterial complex lipids: implications for the pathogenesis of apical periodontitis.

Authors:  Qiang Zhu
Journal:  Iran Endod J       Date:  2010-11-15

7.  Dental calculus is associated with death from heart infarction.

Authors:  Birgitta Söder; Jukka H Meurman; Per-Östen Söder
Journal:  Biomed Res Int       Date:  2014-01-09       Impact factor: 3.411

8.  Dental Calculus Links Statistically to Angina Pectoris: 26-Year Observational Study.

Authors:  Birgitta Söder; Jukka H Meurman; Per-Östen Söder
Journal:  PLoS One       Date:  2016-06-23       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.